Helix BioMedix Announces License Agreement with Rodan & Fields, LLC

BOTHELL, Wash─ Helix BioMedix Inc., a developer of bioactive peptides, announced September 3  that it has licensed its new patent pending PiP3 technology to Rodan + Fields Dermatologists, a clinical skincare brand by Stanford University-trained dermatologists Katie Rodan, M.D. and Kathy Fields, M.D.  According to the terms of the license, Rodan + Fields Dermatologists will develop proprietary formulations for their regimen-based skincare line utilizing the new PiP3 technology with Helix's patented peptides. Rodan + Fields will also support the technology with clinical studies, product education for their independent sales consultants and public relations campaigns. The first of the new products is expected to be introduced in early 2009.

Source: Business Wire